Management of Children With or Exposed to HIV
Summary
- Infants diagnosed with HIV infection while receiving antiretroviral prophylaxis for the prevention of mother-to-child transmission should stop prophylactic therapy and initiate fully active combination ART (Management Guidelines)[DHHS Pediatric]
- More than 20 antiretrovirals have FDA approval for use in children; 16 are available as liquids or chewable tablets (Table 2)
- DHHS and WHO guidelines recommend lopinavir/ritonavir plus 2 NRTIs as a preferred initial therapy for children 14 days of age or older to younger than 3 years of age[DHHS Pediatric; WHO ART]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content